Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP405776.RAD9WUZ4p_9SoRxi_qYLT5SdprvBBKrtHLmIKs5buUUsQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP405776.RAD9WUZ4p_9SoRxi_qYLT5SdprvBBKrtHLmIKs5buUUsQ130_assertion type Assertion NP405776.RAD9WUZ4p_9SoRxi_qYLT5SdprvBBKrtHLmIKs5buUUsQ130_head.
- NP405776.RAD9WUZ4p_9SoRxi_qYLT5SdprvBBKrtHLmIKs5buUUsQ130_assertion description "[Further studies are warranted to determine whether glioma patients exhibiting KIT overexpression and KIT gene amplification may benefit from therapy with anti-KIT RTK inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405776.RAD9WUZ4p_9SoRxi_qYLT5SdprvBBKrtHLmIKs5buUUsQ130_provenance.
- NP405776.RAD9WUZ4p_9SoRxi_qYLT5SdprvBBKrtHLmIKs5buUUsQ130_assertion evidence source_evidence_literature NP405776.RAD9WUZ4p_9SoRxi_qYLT5SdprvBBKrtHLmIKs5buUUsQ130_provenance.
- NP405776.RAD9WUZ4p_9SoRxi_qYLT5SdprvBBKrtHLmIKs5buUUsQ130_assertion SIO_000772 17726262 NP405776.RAD9WUZ4p_9SoRxi_qYLT5SdprvBBKrtHLmIKs5buUUsQ130_provenance.
- NP405776.RAD9WUZ4p_9SoRxi_qYLT5SdprvBBKrtHLmIKs5buUUsQ130_assertion wasDerivedFrom befree-20140225 NP405776.RAD9WUZ4p_9SoRxi_qYLT5SdprvBBKrtHLmIKs5buUUsQ130_provenance.
- NP405776.RAD9WUZ4p_9SoRxi_qYLT5SdprvBBKrtHLmIKs5buUUsQ130_assertion wasGeneratedBy ECO_0000203 NP405776.RAD9WUZ4p_9SoRxi_qYLT5SdprvBBKrtHLmIKs5buUUsQ130_provenance.